Join the Oncology Voice Network. Join for Free
Tips for landing your first MSL role…From a guy who just did with Kyle Householder
Medical Science Liaison MSL career tips landing first MSL role networking for MSLs resume tips for MSLs

Tips for landing your first MSL role…From a guy who just did with Kyle Householder


Share This Article


Summary

My guest today is Kyle Householder, Medical Science Liaison at Teva Pharmaceuticals and we discuss how he landed his first MSL role and tips for anyone out there looking to do the same.

In this episode:

  • What is the first thing to do on the journey to landing an MSL role
  • What’s next after landing the MSL role
  • Networking Do’s and Don’ts
  • Kyle’s suggestions on resumes and cover letters
  • What Tom thinks is important to add on resumes 
  • Kyle’s advice to aspiring MSLs

Click for Source
Medical Science Liaison, MSL career tips, landing first MSL role, networking for MSLs, resume tips for MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN